Pharmacy Operations and Drug Scheduling Act, SBC 2003, c. 77
Section 1
Definitions
Cite as Pharmacy Operations and Drug Scheduling Act, SBC 2003, c. 77, s. 1 · read from BC Laws on November 17, 2026
The text
In this Act:
“application committee” means the application committee established or continued under section 21.1;
“board” means the board, within the meaning of the Health Professions and Occupations Act, for the regulatory college;
“bylaw” means a bylaw made under section 21, 21.1 or 23 by the board;
“care centre” means a centre where patients or clients receive care involving drugs or devices;
“criminal record history” means a criminal record history under section 5.1;
“device” means an article, instrument or apparatus used
(a) to prevent, diagnose, treat or mitigate a disease, disorder or abnormal physical or mental state or a symptom of them,
(b) to restore, correct or modify organic functions,
(c) to diagnose pregnancy, or
(d) to administer a drug,
provided the article, instrument or apparatus meets the criteria listed in the bylaws;
“direct owner” means the owner of a pharmacy, other than an indirect owner;
“director of discipline” means the director of discipline appointed under the Health Professions and Occupations Act;
“discipline panel” means a discipline panel appointed under the Health Professions and Occupations Act;
“dispense” includes the preparation and sale of a drug or device referred to in a prescription and taking steps to ensure the pharmaceutical and therapeutic suitability of a drug or device for its intended use and taking steps to ensure its proper use;
“drug” means a substance or combination of substances used, or for use, in or on the body of a person or animal
(a) to prevent, diagnose, treat or mitigate a disease, disorder or abnormal physical or mental state or a symptom of them, or
(b) to restore, correct or modify organic functions;
“drug schedules” means drug schedules made under section 22;
“facility” means
(a) a community care facility holding a licence under the Community Care and Assisted Living Act that provides residential care to adults,
(b) a registered assisted living residence under the Community Care and Assisted Living Act, or
(c) any other facility that is approved by the minister and meets the criteria set out in the bylaws
in which limited access drugs or devices are distributed;
“former licensee” includes a person whose practice of pharmacy was governed under the Health Professions Act, R.S.B.C. 1996, c. 183, or the Pharmacists, Pharmacy Operations and Drug Scheduling Act, R.S.B.C. 1996, c. 363;
“hospital” means a hospital designated by the minister under section 1 of the Hospital Act and does not include a hospital owned by the government of British Columbia or Canada;
“indirect owner”, in relation to a pharmacy, means,
(a) in respect of a corporation that is traded publicly, the officers and directors of the corporation, and
(b) in respect of a corporation that is not traded publicly,
(i) the officers, directors and shareholders of the corporation, and
(ii) if a subsidiary corporation, the officers, directors and shareholders of the parent corporation;
“information or billing contravention” has the same meaning as under the Pharmaceutical Services Act;
“investigation committee” means the investigation committee, within the meaning of the Health Professions and Occupations Act, for the regulatory college;
“investigator” means an investigator, within the meaning of the Health Professions and Occupations Act, retained or employed by the regulatory college;
“licensee” means a person who holds a licence issued, under the Health Professions and Occupations Act, by the regulatory college;
“limited access drug” means a drug that must not be sold
(a) without a prescription, or
(b) without the supervision or intervention of a licensee in accordance with the drug schedules and bylaws;
“manager” means a licensee who is designated in a pharmacy licence as manager of a pharmacy;
“personal health information” means recorded information about an identifiable individual that is related to the individual's health or the provision of health services to the individual;
“personal representative” means a person having authority under the common law or an enactment to make personal and health care decisions in respect of another person;
“pharmacy” means the area of a premises licensed under this Act, or in respect of which a direct owner seeks to have a pharmacy licence issued, renewed or reinstated, where drugs or devices may be
(a) stored, or
(b) dispensed or sold to the public;
“pharmacy licence” means a pharmacy licence issued, renewed or reinstated under section 4;
“practice of pharmacy” means the practice of the profession that, under the Health Professions and Occupations Act, is the designated health profession of pharmacy;
“practitioner” means a person
(a) who is authorized to practise medicine, dentistry, podiatry or veterinary medicine, or
(b) who is
(i) in a class of persons prescribed by the minister for the purpose of this definition, and
(ii) authorized under the Health Professions Act to prescribe drugs or devices in the course of providing the services of a designated health profession as defined in section 1 of that Act;
“prescription” means an authorization from a practitioner to dispense a specified drug or device for use by a designated individual or animal;
“registrar”, except in section 22 (2.3) and (2.4), means the registrar, within the meaning of the Health Professions and Occupations Act, for the regulatory college;
“regulatory college” means the regulator that is responsible, under the Health Professions and Occupations Act, for governing the designated health profession of pharmacy;
“sale” or “sell” includes barter, distribute, supply, offer, expose, advertise or possess for the purpose of selling, whether or not for consideration;
“support person” means a person who
(a) is not a licensee, and
(b) performs, under the direct supervision of a licensee, technical functions related to the dispensing, distribution or sale of drugs or the operation of a pharmacy;
“therapeutic interchange program” means a program or protocol under which alternate drugs are dispensed in place of prescribed drugs where the alternate drugs have different chemical compositions but essentially the same therapeutic objectives as the prescribed drugs for which they are substituted;
“veterinary drug” means a drug used, or intended or represented to be used, as a drug for the treatment, prevention or diagnosis of a disease of an animal, and includes a drug listed or included by reference in the regulations made under section 13 of the Veterinary Drugs Act;
“wholesaler” means a licensee or other person who qualifies under the bylaws to be a wholesaler and sells or offers for sale drugs or devices
(a) to pharmacies, distributors or other wholesalers for resale, or
(b) to hospitals, facilities and care centres for patient use.
Read the Pharmacy Operations and Drug Scheduling Act on BC Laws ↗